PRUCROS 20MG TAB

About

Prucalopride, potentially at a dosage of 20mg as PRUCROS 20MG TAB (though typical doses are 1mg or 2mg), is a selective, high-affinity 5-hydroxytryptamine 4 (5-HT4) receptor agonist. It is indicated for the symptomatic treatment of chronic idiopathic constipation (CIC) in adults for whom laxatives fail to provide adequate relief. Prucalopride works by stimulating 5-HT4 receptors in the gastrointestinal tract, which enhances colonic motility and promotes bowel movements. This prokinetic action helps to normalize bowel function, increase stool frequency, and improve stool consistency, thereby alleviating the discomfort and symptoms associated with chronic constipation.

Unlike some other prokinetic agents, prucalopride exhibits high selectivity for 5-HT4 receptors, minimizing off-target effects. It is primarily excreted unchanged in the urine, necessitating dose adjustments in patients with renal impairment. The therapeutic benefits include improved quality of life and reduced straining. It is important to note that the typical dose is 1mg or 2mg, and 20mg would be an exceptionally high dose, potentially indicating a different compound or a significant error in the product description.

Uses

• Symptomatic treatment of chronic idiopathic constipation (CIC)
• Relief of constipation symptoms in adults
• Improvement of bowel movement frequency
• Enhancement of colonic motility and transit

Directions For Use

Take one tablet orally once daily, with or without food, as prescribed by your doctor. Do not exceed the recommended dosage.

Benefits

• Effective relief for chronic constipation
• Improves bowel movement frequency
• Enhances colonic transit and function
• Reduces straining during defecation
• Improves stool consistency
• Specific action on gut motility

Side Effects

• Headache
• Nausea
• Diarrhea
• Abdominal pain
• Fatigue
• Dizziness
• Flatulence
• Vomiting
• Dyspepsia
• Anorexia
• Palpitations
• Tremor

Safety Measures

• Alcohol - No specific interaction with alcohol is known, but excessive alcohol consumption can affect gut motility and hydration, potentially worsening constipation.
• Pregnancy - Prucalopride is not recommended during pregnancy. Women of childbearing potential should use effective contraception during treatment.
• Breastfeeding - Prucalopride is excreted in human milk. Breastfeeding is not recommended during treatment with this medication.
• Liver - No dose adjustment is generally required in patients with mild to moderate hepatic impairment. Use with caution in severe hepatic impairment.
• Kidney - Dose adjustment is required in patients with severe renal impairment (creatinine clearance <30 mL/min).
• Lung - No specific precautions are generally required for patients with lung conditions, as prucalopride primarily affects the gastrointestinal system.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.